Francis A. Ennis
#136,064
Most Influential Person Now
Francis A. Ennis's AcademicInfluence.com Rankings
Francis A. Ennisbiology Degrees
Biology
#9342
World Rank
#12537
Historical Rank
Virology
#214
World Rank
#221
Historical Rank
Microbiology
#498
World Rank
#559
Historical Rank
Download Badge
Biology
Francis A. Ennis's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Microbiology Stanford University
Similar Degrees You Can Earn
Why Is Francis A. Ennis Influential?
(Suggest an Edit or Addition)Francis A. Ennis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. (2000) (1591)
- Early clinical and laboratory indicators of acute dengue illness. (1997) (684)
- High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. (2002) (670)
- Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. (2002) (518)
- Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. (1988) (457)
- Dengue in the early febrile phase: viremia and antibody responses. (1997) (454)
- Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. (2002) (427)
- Immunopathogenesis of Dengue hemorrhagic fever. (1999) (418)
- Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. (1999) (396)
- Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. (1977) (365)
- Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. (2004) (340)
- Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. (1991) (333)
- Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. (1990) (284)
- Human Dendritic Cells Are Activated by Dengue Virus Infection: Enhancement by Gamma Interferon and Implications for Disease Pathogenesis (2001) (260)
- HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. (2002) (254)
- Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. (1999) (231)
- Human cytotoxic T-cell memory: long-lived responses to vaccinia virus (1996) (216)
- Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. (2016) (214)
- A live, attenuated recombinant West Nile virus vaccine. (2006) (213)
- Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones (1999) (213)
- High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. (1999) (208)
- Human Cytotoxic T-Lymphocyte Repertoire to Influenza A Viruses (1998) (206)
- Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study (2007) (203)
- Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity (1999) (203)
- Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. (2008) (187)
- Natural History of Plasma Leakage in Dengue Hemorrhagic Fever: A Serial Ultrasonographic Study (2007) (179)
- Dose-related effects of smallpox vaccine. (2002) (177)
- Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. (2002) (173)
- Role of Specific CD8+ T Cells in the Severity of a Fulminant Zoonotic Viral Hemorrhagic Fever, Hantavirus Pulmonary Syndrome1 (2004) (169)
- Increased Production of Interleukin-8 in Primary Human Monocytes and in Human Epithelial and Endothelial Cell Lines after Dengue Virus Challenge (2002) (166)
- Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. (1999) (165)
- Summary of clinical trials of inactivated influenza vaccine - 1978. (1983) (157)
- Dengue Virus Induces Novel Changes in Gene Expression of Human Umbilical Vein Endothelial Cells (2003) (157)
- Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. (1981) (154)
- Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity (1989) (149)
- Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones (1991) (149)
- Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. (1989) (147)
- IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. (1999) (146)
- Clonal vaccinia virus grown in cell culture as a new smallpox vaccine (2003) (144)
- Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever (2006) (137)
- Predominance of HLA-Restricted Cytotoxic T-Lymphocyte Responses to Serotype-Cross-Reactive Epitopes on Nonstructural Proteins following Natural Secondary Dengue Virus Infection (1998) (137)
- Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. (2002) (136)
- Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201–restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses (2003) (134)
- High levels of interferon alpha in the sera of children with dengue virus infection. (1993) (133)
- Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. (1981) (133)
- Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. (1996) (131)
- Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. (1997) (129)
- Long-lived Memory T Lymphocyte Responses After Hantavirus Infection (2002) (126)
- Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells (1988) (124)
- A Blunted Blood Plasmacytoid Dendritic Cell Response to an Acute Systemic Viral Infection Is Associated with Increased Disease Severity 1 (2003) (121)
- Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. (2001) (120)
- Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring. (2014) (120)
- A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. (1977) (117)
- Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS). (1999) (116)
- Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. (1994) (114)
- Impaired T cell proliferation in acute dengue infection. (1999) (112)
- Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes (1989) (112)
- Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. (2002) (112)
- Molecular evolution of dengue type 2 virus in Thailand. (1998) (110)
- Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. (2005) (108)
- Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. (1995) (107)
- Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. (2002) (105)
- Dengue--how best to classify it. (2011) (105)
- Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005. (2010) (105)
- An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag (1991) (104)
- Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections (2002) (103)
- T Cell Responses to an HLA-B*07-Restricted Epitope on the Dengue NS3 Protein Correlate with Disease Severity1 (2002) (103)
- High levels of viremia in patients with the Hantavirus pulmonary syndrome. (1999) (103)
- Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones (1996) (100)
- Influenza virus infection in nude mice. (1976) (100)
- INTERFERON INDUCTION AND INCREASED NATURAL KILLER-CELL ACTIVITY IN INFLUENZA INFECTIONS IN MAN (1981) (100)
- Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity (1984) (98)
- HLA-RESTRICTED VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES TO LIVE AND INACTIVATED INFLUENZA VACCINES (1981) (96)
- Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge. (2007) (95)
- Human Memory Cytotoxic T-Lymphocyte (CTL) Responses to Hantaan Virus Infection: Identification of Virus-Specific and Cross-Reactive CD8+ CTL Epitopes on Nucleocapsid Protein (1999) (94)
- Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. (1999) (91)
- Cytotoxic T lymphocyte response to murine cytomegalovirus infection (1978) (90)
- Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. (1991) (89)
- Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription‐polymerase chain reaction (2001) (87)
- Analysis of Murine CD8+ T-Cell Clones Specific for the Dengue Virus NS3 Protein: Flavivirus Cross-Reactivity and Influence of Infecting Serotype (1999) (85)
- Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies (2011) (84)
- Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. (1997) (84)
- Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. (1980) (84)
- Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R (1990) (82)
- Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. (2004) (79)
- Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes (1992) (78)
- Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4. (1998) (78)
- Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination (1993) (77)
- Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever (1994) (76)
- T Cells and Pathogenesis of Hantavirus Cardiopulmonary Syndrome and Hemorrhagic Fever with Renal Syndrome (2011) (76)
- Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells. (1985) (74)
- TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. (2009) (74)
- The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. (1978) (74)
- Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus (1996) (74)
- Immunologic responses to vaccinia vaccines administered by different parenteral routes. (1997) (73)
- Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus (1981) (72)
- Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? (2007) (70)
- Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines. (1977) (70)
- Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. (1983) (70)
- The persistently troublesome cough (2001) (69)
- Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans (1993) (69)
- Human CD8+ T Cell Memory Generation in Puumala Hantavirus Infection Occurs after the Acute Phase and Is Associated with Boosting of EBV-Specific CD8+ Memory T Cells1 (2007) (68)
- A Comparative Study of Leptospirosis and Dengue in Thai Children (2007) (68)
- Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. (2009) (68)
- Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones. (1995) (67)
- Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases. (2009) (66)
- Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. (2010) (66)
- Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine. (1994) (65)
- Influenza A viruses of the H2N2 subtype are lymphocyte mitogens (1978) (65)
- Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes (1993) (65)
- Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. (2006) (64)
- Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. (2007) (62)
- Hemagglutinin-specific cytotoxic T-cell response during influenza infection (1977) (61)
- Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones (1996) (61)
- Evidence that cytotoxic T cells are part of the host's response to influenza pneumonia (1978) (60)
- Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity. (1968) (60)
- Microevolution of Dengue Viruses Circulating among Primary School Children in Kamphaeng Phet, Thailand (2008) (60)
- Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. (1977) (59)
- HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. (1988) (59)
- Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. (2004) (58)
- Production of interferon alpha by dengue virus-infected human monocytes. (1988) (58)
- Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. (1998) (57)
- Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections (2005) (57)
- A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6 (1992) (57)
- Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. (1991) (56)
- In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses. (2009) (55)
- Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone (1993) (55)
- Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. (1973) (54)
- Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial (2005) (54)
- Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein. (1991) (53)
- Identification of Murine Poxvirus-Specific CD8+ CTL Epitopes with Distinct Functional Profiles1 (2005) (53)
- Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein (2016) (53)
- High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children. (2015) (53)
- Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses (1994) (52)
- Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine. (2001) (52)
- Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. (2007) (52)
- Influenza immunization policies and practices in Japan. (1980) (51)
- Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones (1992) (51)
- Human immune responses to dengue viruses. (1990) (50)
- Definition of the region on NS3 which contains multiple epitopes recognized by dengue virus serotype-cross-reactive and flavivirus-cross-reactive, HLA-DPw2-restricted CD4+ T cell clones. (1998) (50)
- Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro (1978) (50)
- Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. (2008) (49)
- Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. (1995) (48)
- Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli (1985) (47)
- Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice. (1997) (46)
- Review of existing vaccines for influenza. (1978) (46)
- Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines. (1982) (45)
- Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. (2009) (45)
- A single nine-amino acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of heterogeneous serotype specificities (1995) (45)
- MIP‐1α and MIP‐1β induction by dengue virus (2001) (45)
- Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. (2002) (44)
- Dengue Viral RNA Levels in Peripheral Blood Mononuclear Cells Are Associated with Disease Severity and Preexisting Dengue Immune Status (2012) (44)
- Latent cytomegalovirus infection of BALB/c mouse spleens detected by an explant culture technique. (1979) (44)
- Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins (1989) (43)
- Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120. (1992) (43)
- Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses (2007) (43)
- New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion. (1980) (43)
- Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections. (2014) (42)
- Influenza A Virus Matrix Protein 1-Specific Human CD8+ T-Cell Response Induced in Trivalent Inactivated Vaccine Recipients (2008) (42)
- Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children. (2014) (42)
- Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. (1980) (42)
- Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones. (1997) (41)
- Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. (1986) (40)
- The Degree of Leukocytosis and Urine GATA-3 mRNA Levels Are Risk Factors for Severe Acute Kidney Injury in Puumala Virus Nephropathia Epidemica (2012) (40)
- Cross-reactive human B cell and T cell epitopes between influenza A and B viruses (2013) (39)
- Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. (1986) (39)
- Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone. (1991) (38)
- Influenza vaccine: split-product versus whole-virus types--How do they differ. (1977) (38)
- Immune mediated and inherited defences against flaviviruses. (1998) (38)
- Host Defense Mechanisms Against Herpes Simplex Virus I. Control of Infection In Vitro by Sensitized Spleen Cells and Antibody (1973) (38)
- Cytotoxic T lymphocytes induced in mice by inactivated influenza virus vaccine (1977) (38)
- FcR-mediated enhancement of HIV-1 infection by antibody. (1990) (38)
- Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. (2008) (37)
- Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7. (2006) (37)
- Further attenuated live measles vaccines: the need for revised recommendations. (1977) (37)
- Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes (1987) (37)
- Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones (1994) (37)
- Immunity to mumps in an institutional epidemic. Correlation of insusceptibility to mumps with serum plaque neutralizing and hemagglutination-inhibiting antibodies. (1969) (37)
- Isolation of virus during the incubation period of mumps infection. (1968) (36)
- Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. (1977) (36)
- A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytes. (2010) (35)
- Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice. (1997) (35)
- Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses1 (2007) (34)
- Dengue virus infection of human skin fibroblasts in vitro production of IFN-β, IL-6 and GM-CSF (2005) (34)
- Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor. (2008) (33)
- A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus (2012) (33)
- Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. (1990) (32)
- Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes (1989) (32)
- Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these. (2005) (31)
- Evaluation of Cardiac Involvement in Children with Dengue by Serial Echocardiographic Studies (2015) (31)
- Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection. (1993) (31)
- Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes. (1983) (31)
- Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus-infected cells. (1986) (30)
- Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses. (1978) (30)
- Cytotoxic T lymphocytes in dengue virus infection. (1994) (30)
- International collaborative study of single-radial-diffusion and immunoelectrophoresis techniques for the assay of haemagglutinin antigen of influenza virus. (1981) (29)
- T-cell Responses to Dengue Virus in Humans (2011) (29)
- Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining. (2004) (28)
- T cell receptor Vbeta gene usage in Thai children with dengue virus infection. (2001) (27)
- Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine (1980) (27)
- Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. (1989) (27)
- Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination. (2011) (27)
- T cell activation in vivo by dengue virus infection. (1995) (27)
- Influenza vaccine in unprimed children: improved immunogenicity with few reactions following one high dose of split-product vaccine. (1980) (26)
- Definition of Amino Acid Residues on the Epitope Responsible for Recognition by Influenza A Virus H1-Specific, H2-Specific, and H1- and H2-Cross-Reactive Murine Cytotoxic T-Lymphocyte Clones (1998) (26)
- Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines. (1977) (26)
- Effect of priming infection on serologic response to whole and subunit influenza virus vaccines in animals. (1977) (25)
- Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. (2008) (25)
- Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. (2007) (25)
- Early CD 69 Expression on Peripheral Blood Lymphocytes from Children with Dengue Hemorrhagic Fever (1999) (24)
- Cytokine production by dengue virus antigen‐responsive human T lymphocytes in vitro examined using a double immunocytochemical technique (1997) (24)
- Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccine. (1992) (24)
- Immune control of herpes simplex virus infections. (1974) (23)
- Primary influenza A virus infection induces cross-reactive antibodies that enhance uptake of virus into Fc receptor-bearing cells. (1994) (23)
- Altered effector functions of virus‐specific and virus cross‐reactive CD8+ T cells in mice immunized with related flaviviruses (2010) (23)
- Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection. (1978) (22)
- Robust Intrapulmonary CD8 T Cell Responses and Protection with an Attenuated N1L Deleted Vaccinia Virus (2008) (22)
- Dengue Vaccine: The Need, the Challenges, and Progress. (2016) (22)
- Hydrocephalus in hamsters: induction by natural and attenuated mumps viruses. (1969) (22)
- Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli (1985) (21)
- Human influenza A virus: comparative analysis of the structural polypeptides by two-dimensional polyacrylamide gel electrophoresis. (1979) (21)
- Herpes simplex virus vaccines. (1977) (21)
- Assessment of body fluid compartment volumes by multifrequency bioelectrical impedance spectroscopy in children with dengue. (2002) (19)
- Mitogenicity of influenza hemagglutinin glycoproteins and influenza viruses bearing H2-hemagglutinin (1981) (19)
- The elimination of herpes simplex plaques by antibody and the emergence of resistant strains. (1977) (19)
- Transient decreases in human T cell proliferative responses following vaccinia immunization. (2000) (18)
- Preferential usage of T-cell receptor V beta 17 by dengue virus-specific human T lymphocytes in a donor with immunity to dengue virus type 4 (1994) (17)
- Cytotoxic T-cell and antibody responses to influenza infection of mice. (1979) (16)
- Identification and analysis for cross-reactivity among hantaviruses of H-2b-restricted cytotoxic T-lymphocyte epitopes in Sin Nombre virus nucleocapsid protein. (2004) (16)
- Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin. (1993) (16)
- CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus–Vaccinated Humans (2013) (16)
- Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals (2012) (15)
- Comparison of new triton X-100- and tween-ether-treated split-treated vaccines in children (1981) (14)
- Human immunity to viruses (1983) (14)
- Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1) (2013) (14)
- Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses. (2010) (13)
- Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture. (1993) (13)
- Microplate-reverse hybridization method to determine dengue virus serotype. (1998) (13)
- A Plaque Neutralization Test for Determining Mumps Antibodies (1968) (12)
- Clinical studies with virulent and attenuated mumps viruses. (1969) (12)
- High-yield reassortant influenza vaccine production virus has a mutation at an HLA-A 2.1-restricted CD8+ CTL epitope on the NS1 protein. (1999) (12)
- Modulation of the functions of dengue virus-specific human CD8+ cytotoxic T cell clone by IL-2, IL-7 and IFN gamma. (1995) (11)
- Effect of rimantadine on cytotoxic T lymphocyte responses and immunity to reinfection in mice infected with influenza A virus. (1990) (11)
- Using HLA-transgenic mice to identify immunodominant human CD8+ T cell epitopes--does (genome) size matter? (2006) (10)
- Recombination of influenza A virus strains: effect on pathogenicity. (1976) (10)
- Definition of the region on NS 3 which contains multiple epitopes recognized by dengue virus serotype-cross-reactive and flavivirus-cross-reactive , HLA-DPw 2-restricted CD 4 M T cell clones (1998) (10)
- Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones. (1997) (9)
- Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72 (1976) (9)
- Comparative antigenicity and immunogenicity of 1976 influenza virus vaccines: results of mouse protection experiments. (1978) (9)
- T cell receptor Vβ gene usage in Thai children with dengue virus infection (2001) (9)
- Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. (2008) (9)
- Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons. (1993) (9)
- Reduction of endotoxin levels in influenza virus vaccines by barium sulfate adsorption-elution. (1975) (8)
- Nuclear Export Signal and Immunodominant CD8+ T Cell Epitope in Influenza A Virus Matrix Protein 1 (2012) (8)
- Cell-mediated immunity in cytomegalovirus infections--a review. (1980) (8)
- Immunomodulatory effects of IL-7 on dengue virus-specific cytotoxic CD4+ T cell clones. (1996) (7)
- Host defense mechanisms against infection with influenza virus. I. Effect of sensitized spleen cells on infection in vitro. (1974) (7)
- Endotoxin content and clinical reactivity to influenza vaccines. (1977) (7)
- Sensitive neutralization test for virus antibody (1978) (7)
- Serologic responses after two sequential doses of influenza A/New Jersey/76 virus vaccine in normal young adults. (1977) (6)
- Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines. (2011) (6)
- Assessment of human CD4+ and CD8+ T lymphocyte responses in experimental viral vaccine studies. (1998) (6)
- Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice. (1980) (6)
- Protective cross-reactive epitope on the nonstructural protein NS1 of influenza A virus. (1993) (6)
- Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies (2012) (5)
- Lymphocyte proliferative responses to dengue virus E and NS1 proteins in BALB/c mice. (1990) (5)
- Dengue: translating scientific progress into workable solutions (2005) (5)
- Tumor necrosis factor ( TNF ) and lymphotoxin-alpha ( LTA ) gene , allele , and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais (2009) (5)
- Detection of cells producing surface antigen-specific antibody to influenza viruses (1978) (5)
- Age and different influenza viruses. (2014) (5)
- Quantitation of antibody-bound and unbound Sin Nombre virus in the plasma of patient with hantavirus pulmonary syndrome. (2003) (5)
- Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses. (1977) (4)
- Control of measles and rubella through use of attenuated vaccines. (1978) (4)
- Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones. (2003) (4)
- Immunization with the N-terminal region of the nonstructural protein NS1 promotes survival after challenge with lethal influenza A virus dose. (1998) (4)
- Efficacy of rimantadine hydrochloride in the treatment of influenza infection of mice. (1989) (4)
- Dengue Hemorrhagic Fever: the sensitivity and specificity of the WHO definition in identifying severe dengue cases in Thailand, 1994-2005 (2010) (4)
- Epidemiology of the Influenza A Virus H5N1 Subtype and Memory of Immunity to the H2N2 Subtype (2012) (4)
- Dengue Virus Induces Novel Changes in Gene Expression of Human Umbilical Vein Endothelial Cells (2004) (3)
- Human T lymphocyte responses to dengue viruses: recognition of dengue virus proteins by T lymphocytes. (1990) (3)
- Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system (2020) (3)
- Influenza Research in the Soviet Union—1974 (1974) (3)
- Reply to Halstead and to Burke and Kliks (2006) (3)
- Establishment of dengue virus-specific human CD4+ T lymphocyte clones from Percoll-purified T lymphoblasts by stimulation with monoclonal antibody to CD3. (1995) (3)
- Regulatory approach toward vaccines against cancer: the benefit/risk ratio. (1976) (2)
- Kinetics and specificity at the clonal level of the cytotoxic T lymphocyte response to influenza pneumonia. (1987) (2)
- Amplified HIV Transmission during Early-Stage Infection (2011) (2)
- NIAID workshop on Flavivirus immunity. (2010) (2)
- Recovery from a Viral Respiratory Tract Infection: III. Specificity of Protection Conferred by Immune Spleen Cells Stimulated In Vitro (1981) (2)
- An assay for virus-specific help for B cells. (1981) (2)
- Corrigendum to “Vaccinia virus-specific CD8+ T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans” [Hum. Immunol. 69 (2007) 815–825] (2009) (2)
- A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus (2013) (2)
- Influenza A viruses: shaking out our shibboleths (1978) (1)
- Elimination of Infection (2008) (1)
- Distinct recognition of influenza virus hemagglutinin and H-2 antigens by cytotoxic thymus derived lymphocytes. (1977) (1)
- Profiles CTL Epitopes with Distinct Functional + CD 8 Identification of Murine Poxvirus-Specific (2005) (0)
- Response to influenza pneumonia. (1978) (0)
- Definition ofanHLA-DPw2-Restricted Epitope onNS3, Recognized byaDengueVirus Serotype-Cross-Reactive HumanCD4+CD8-Cytotoxic T-Cell Clone (1993) (0)
- A novel plaque method for attenuated rubella virus in Vero cell cultures (2005) (0)
- Virus Proteins A24R and D1R Conserved HLA-DR1-Restricted Epitopes on Vaccinia Human Cytotoxic CD4+ T Cells Recognize (2013) (0)
- Polypeptide for vaccine (1989) (0)
- INDUCTION OF IMMUNE INTERFERON FROM HUMAN LYMPHOCYTES BY INFLUENZA-INFECTED STIMULATOR CELLS (1982) (0)
- Cytotoxic t and helper cells in influenza pneumonia. Abstr. (1980) (0)
- Reduction of Endotoxin Levels in Influenza Virus Vaccines by Barium Sulfate Adsorption-Elution (1975) (0)
- Severity Infection Is Associated with Increased Disease Response to an Acute Systemic Viral A Blunted Blood Plasmacytoid Dendritic Cell (2003) (0)
- Immunisation a reaction croisee contre le virus de la grippe a (1994) (0)
- Cross-reactive human B cell and T cell epitopes between influenza A and B viruses (2013) (0)
- Persistence 12 months: of maternal Mechanism antibody in infants beyond of measles vaccine failure (1977) (0)
- Fever, Hantavirus Pulmonary Syndrome of a Fulminant Zoonotic Viral Hemorrhagic T Cells in the Severity + Role of Specific CD8 (2004) (0)
- Influenza A Virus Matrix Protein 1-Specific Human CD8 (cid:1) T-Cell Response Induced in Trivalent Inactivated Vaccine Recipients (cid:1) (2008) (0)
- Coadministered with Protein Immunogens and Systemic Immune Responses When IL-1 Is an Effective Adjuvant for Mucosal (1999) (0)
- Poxviruses Virus Proteins A 24 R and D 1 R Conserved HLA-DR 1-Restricted Epitopes on Vaccinia T Cells Recognize + Human Cytotoxic CD 4 (2007) (0)
- Human Immune Responses to Experimental Vaccinia Vaccines. (1996) (0)
- Complement-depleted mice exhibit delayed influenza virus elimination in vivo. Abstr. (1978) (0)
- Potential for Cross-Reactive Protection Using Peptides and Adjuvants or Carrier Molecules (1985) (0)
- Potential for Therapy with Immune Interferon. (1984) (0)
- Cytotoxic T-cell responses to influenza infection in mice (1-6) and after immuni- (2003) (0)
- Immune Control of Herpes Simplex Virus Infections 1 (2006) (0)
- SerotypeResponse to a Heterologous Dengue Virus Partial Agonist Effect Influences the CTL (1999) (0)
- T-lymphocyte clones . serotype-cross-reactive human CD 4 + cytotoxic serotype-specific and a panel of virus capsid protein recognized by a Identification of two epitopes on the dengue 4 (1995) (0)
- Reply to Akbar et al (2012) (0)
- Human Immune Response to HTLV-III Virus Infection in Acquired Immunodeficiency Syndrome (1990) (0)
- Human Immune Responses to HTLV-III Virus Infections in the Acquired Immunodeficiency Syndrome (1988) (0)
- Human Immune Response to Dengue Infections. (1991) (0)
- Prospective study of dengue virus transmission and disease in primary school children in Kamphaeng Phet, Thailand (1999) (0)
- Hemagglutinin specificity of cytotoxic t lymphocytes is responsible for recovery from influenza virus pneumonia. Abstr. (1981) (0)
- T CELL RECEPTOR V (cid:1) GENE USAGE IN THAI CHILDREN WITH DENGUE VIRUS INFECTION (2001) (0)
- SEROLOGICALLY DOCUMENTED MATERNAL INFLUENZA AND BIPOLAR DISORDER IN ADULT OFFSPRING (2014) (0)
- Identification of amino acids involved in recognition by dengue virus NS 3-specific , HLA-DR 15-restricted cytotoxic CD 4 + T-cell clones (2017) (0)
- Evidence that the mitogenic activity of h2n2 influenza a viruses is associated with the h2 hemagglutinin. Abstr. (1978) (0)
- Cells Memory T + Boosting of EBV-Specific CD 8 the Acute Phase and Is Associated with Puumala Hantavirus Infection Occurs after T Cell Memory Generation in + Human CD 8 (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Francis A. Ennis?
Francis A. Ennis is affiliated with the following schools:
